Calcineurin/NFATc1 pathway contributes to cell proliferation in hepatocellular carcinoma

Digestive Diseases and Sciences

Volumn 57, Issue 12, 2012, Pages 3184-3188

  Wang, Shuhuai ^a   Kang, Xinmei ^a   Cao, Shouqiang ^a   Cheng, Hui ^a   Wang, Di ^a   Geng, Jingshu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Calcineurin; Hepatocellular carcinoma; NFATc1; Proliferation

Indexed keywords

CALCINEURIN; NUCLEAR FACTOR OF ACTIVATED T CELL C1; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRAIN HEPG2; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; CALCINEURIN; CALCIUM; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; NFATC TRANSCRIPTION FACTORS; ONCOGENES; SIGNAL TRANSDUCTION;

EID: 84871636747     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2255-8     Document Type: Article

References (16)

1. Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. 2005;5:472-484.
2. Lu H, Huan C. Transcription factor NFAT, its role in cancer development, and as a potential target for chemoprevention. Curr Cancer Drug Targets. 2007;7:343-353.
3. Müller MR, Rao A. NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol. 2010;10:645-656.
4. Oum JH, Han J, Myung H, Hleb M, Sharma S, Park J. Molecular mechanism of NFAT family proteins for differential regulation of the IL-2 and TNF-alpha promoters. Mol Cells. 2002;13:77-84.
5. Horsley V, Aliprantis AO, Polak L, Glimcher LH, Fuchs E. NFATc1 balances quiescence and proliferation of skin stem cells. Cell. 2008;132:299-310.
6. Neal JW, Clipstone NA. A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts. J Biol Chem. 2003;278:17246-17254.
7. Giglia JL, Antonia SJ, Berk LB, Bruno S, Dessureault S, Finkelstein SE. Systemic therapy for advanced hepatocellular carcinoma: past, present, and future. Cancer Control. 2010;17:120-129.
8. Mahnken AH, Bruners P, Günther RW. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation. Dig Dis. 2009;27:148-156.
9. Boucher E, Forner A, Reig M, Bruix J. New drugs for the treatment of hepatocellular carcinoma. Liver Int. 2009;29:148-158.
10. Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, Crabtree GR. Identification of a putative regulator of early T cell activation genes. Science. 1988;241:202-205.
11. Mancini M, Toker A. NFAT proteins: emerging roles in cancer progression. Nat Rev Cancer. 2009;9:810-820.
12. Kao SC, Wu H, Xie J, et al. Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science. 2009;323:651-654.
13. Gordan JD, Thompson CB, Simon MC. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell. 2007;12:108-113.
14. Singh G, Singh SK, König A, et al. Sequential activation of NFAT and c-Myc transcription factors mediates the TGF-beta switch from a suppressor to a promoter of cancer cell proliferation. J Biol Chem. 2010;285:27241-27250.
15. Cervello M, Montalto G. Cyclooxygenases in hepatocellular carcinoma. World J Gastroenterol. 2006;12:5113-5121.
16. Stasinopoulos I, O'Brien DR, Wildes F, Glunde K, Bhujwalla ZM. Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells. Mol Cancer Res. 2007;5:435-442.